Mycobacterium scrofulaceum disease: experience from a tertiary medical centre and review of the literature

References

• Prissick F, Masson A. Cervical lymphadenitis in children caused by chromogenic mycobacteria. Can Med Assoc J. 1956;75:798.
   PubMedGoogle Scholar
• Prissick F, Masson A. Yellow-pigmented pathogenic mycobacteria from cervical lymphadenitis. Can J Microbiol. 1957;3:91–100.
   PubMed Web of Science ®Google Scholar
• Kirschner RA, Jr Parker BC, Falkinham JO, III. Epidemiology of infection by nontuberculous mycobacteria. Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. Am Rev Respir Dis. 1992;145:271–275.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Morino E, Ishii M, et al. Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in 2001–2011: a case series and literature review. J Inf Chemother. 2016;22:611–616.
   PubMed Web of Science ®Google Scholar
• Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis. 1995;20:954–963.
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.
   PubMed Web of Science ®Google Scholar
• Hall L, Doerr KA, Wohlfiel SL, et al. : Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory. J Clin Microbiol. 2003;41:1447–1453.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. CLSI Standard M24. 3rd ed. PA, USA: CLSI Wayne; 2018.
   Google Scholar
• Lincoln EM, Gilbert LA. Disease in children due to mycobacteria other than Mycobacterium tuberculosis. Am Rev Respir Dis. 1972;105:683–714.
   PubMed Web of Science ®Google Scholar
• Hautmann G, Lotti T. Diseases caused by Mycobacterium scrofulaceum. Clin Dermatol. 1995;13:277–280.
   PubMed Web of Science ®Google Scholar
• Lai KK, Stottmeier KD, Sherman IH, et al. Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. Jama. 1984;251:1286–1288.
   PubMed Web of Science ®Google Scholar
• Marais BJ, Wright CA, Schaaf HS, et al. Tuberculous lymphadenitis as a cause of persistent cervical lymphadenopathy in children from a tuberculosis-endemic area. Pediatr Infect Dis J. 2006;25:142–146.
   PubMed Web of Science ®Google Scholar
• Heraud D, Carr RD, McKee J, et al. Nontuberculous mycobacterial adenitis outside of the head and neck region in children: a case report and systematic review of the literature. Int J Mycobacteriol. 2016;5:351–353.
   PubMed Web of Science ®Google Scholar
• Corbett E, Hay M, Churchyard G, et al. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberculosis Lung Dis. 1999;3:501–507.
   PubMed Web of Science ®Google Scholar
• Corbett EL, Blumberg L, Churchyard GJ, et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med. 1999;160:15–21.
   PubMed Web of Science ®Google Scholar
• Zweijpfenning SM, van Ingen J, Hoefsloot W. Geographic distribution of nontuberculous mycobacteria isolated from clinical specimens: a systematic review. In: Seminars in respiratory and critical care medicine: 2018. New York, USA: Thieme Medical Publishers; 2018. p. 336–342.
   Google Scholar
• Spaulding AB, Lai YL, Zelazny AM, et al. Geographic distribution of nontuberculous mycobacterial species identified among clinical isolates in the United States, 2009-2013. Ann Am Thorac Soc. 2017;14:1655–1661.
   PubMed Web of Science ®Google Scholar
• Emori M, Kajiki A, Ikedo Y, et al. 15 cases of pulmonary Mycobacterium scrofulaceum infection. Kekkaku 2007;82:173–178.
   PubMedGoogle Scholar
• Wickremasinghe M, Ozerovitch L, Davies G, et al. Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax. 2005;60:1045–1051.
   PubMed Web of Science ®Google Scholar
• Olivier KN, Weber DJ, Wallace Jr RJ, et al. Nontuberculous mycobacteria: I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167:828–834.
   PubMed Web of Science ®Google Scholar
• Covert TC, Rodgers MR, Reyes AL, et al. Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol. 1999;65:2492–2496.
   PubMed Web of Science ®Google Scholar
• Vaerewijck MJ, Huys G, Palomino JC, et al. Mycobacteria in drinking water distribution systems: ecology and significance for human health. FEMS Microbiol Rev. 2005;29:911–934.
   PubMed Web of Science ®Google Scholar
• Brown-Elliott BA, Nash KA, Wallace RJ. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012;25:545–582.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. 3rd ed. CLSI standard M62. Wayne, PA: CLSI Wayne; 2018
   Google Scholar
• Sirgel FA, Warren RM, Streicher EM, et al. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother. 2012;67:1088–1093.
   PubMed Web of Science ®Google Scholar
• Curry International Tuberculosis Center and California Department of Public Health. Drug-resistant tuberculosis: a survival guide for clinicians. Oakland, USA: Curry International Tuberculosis Center. 2016. p. 31–98.
   Google Scholar
• van Ingen J, Boeree MJ, van Soolingen D, et al. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat. 2012;15:149–161.
   PubMed Web of Science ®Google Scholar